Cargando…
A highly sensitive fluorimetric method for determination of lenalidomide in its bulk form and capsules via derivatization with fluorescamine
BACKGROUND: Lenalidomide (LND) is a potent novel thalidomide analog which demonstrated remarkable clinical activity in treatment of multiple myeloma disease via a multiple-pathways mechanism. The strong evidences-based clinical success of LND in patients has led to its recent approval by US-FDA unde...
Autores principales: | Darwish, Ibrahim A, Khalil, Nasr Y, Bakheit, Ahmed H, Alzoman, Nourh Z |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537752/ https://www.ncbi.nlm.nih.gov/pubmed/23068782 http://dx.doi.org/10.1186/1752-153X-6-118 |
Ejemplares similares
-
Trace determination of lenalidomide in plasma by non-extractive HPLC procedures with fluorescence detection after pre-column derivatization with fluorescamine
por: Khalil, Nasr Y, et al.
Publicado: (2013) -
Determination of Sulfonamides in Feeds by High-Performance Liquid Chromatography after Fluorescamine Precolumn Derivatization
por: Patyra, Ewelina, et al.
Publicado: (2019) -
Synthesis of hapten and preparation of specific polyclonal antibody with high affinity for lenalidomide, the potent drug for treatment of multiple myeloma
por: Darwish, Ibrahim A, et al.
Publicado: (2012) -
Selective Spectrophotometric and Spectrofluorometric Methods for the Determination of Amantadine Hydrochloride in Capsules and Plasma via Derivatization with 1,2-Naphthoquinone-4-sulphonate
por: Mahmoud, Ashraf M., et al.
Publicado: (2009) -
Hantzsch pre-column derivatization for simultaneous determination of alendronate sodium and its pharmacopoeial related impurity: Comparative study with synchronous fluorometry using fluorescamine
por: El-Yazbi, Amira F., et al.
Publicado: (2018)